Table 2.
PRLR variant | Predicted pathogenicity | STAT5 signalling | PI3K/ Akt signalling | Cell viability | Apoptosis | |||||
---|---|---|---|---|---|---|---|---|---|---|
Prediction programsa | Evolutionary conservationb | Structural predictions | pSTAT5 | CISH | pAkt | FOXO1 | ||||
WT | 0 | N/A | N/A | ++ | ++ | ++ | ++ | ++ | ++ | |
His188Arg | 4 | 4 | Affects PRL binding | - | - | - | - | ++ | +++ | |
ECD |
Tyr99His | 3 | 4 | Affects PRL binding | + | + | ++ | ++ | ++ | ++ |
ECD | Glu145Asp | 3 | 4 | Loss and gain of contacts | ++ | ++ | ++ | ++ | ++ | ++ |
ECD | Glu155Lys | 3 | 3 | Disrupts homodimer region | + | + | ++ | + | ++ | ++ |
ECD | Arg183His | 2 | 4 | Loses contact with WSxWS motif | ++ | ++ | ++ | ++ | ++ | ++ |
ECD | Asp187Glu | 3 | 4 | Loses contact with His188 | - | + | + | ++ | ++ | ++ |
ICD |
Phe255Ser | 4 | 4 | LID1, close to JAK2 binding site | - | + | ++ | ++ | +++ | ++ |
ICD | Gly263Asp | 4 | 4 | LID1 | ++ | ++ | ++ | ++ | ++ | ++ |
ICD | Asp320Tyr | 2 | 4 | Unknown | ++ | ++ | ++ | ++ | ++ | ++ |
ICD | Arg327Gln | 1 | 2 | Degradation motif | +++ | +++ | +* | ++ | +++ | ++ |
ICD | Val535Met | 4 | 4 | Unknown | ++ | ++ | ++ | ++ | ++ | ++ |
aA score out of four based on protein predictions using SIFT, Polyphen-2, MutationTaster, and REVEL is given. If the variant was predicted to be probably damaging or damaging/pathogenic, it was classified as affected; bEvolutionary conservation was based on the PRLR ortholog sequence in four species (cow, dog, mouse, and rat) in comparison to the human protein. The score shows the number of species in which the residue is conserved out of 4; +++Gain of function; ++Normal; +Impaired; -Abolished.;*Arg327Gln has significantly increased basal Akt activity, which likely accounts for the impaired PRL-induced activity.
N/A, not applicable.